James Y. Chen

CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma

Ranjana H. Advani, Ian W. Flinn, Leslie Popplewell et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

Identification and Specification of the Mouse Skeletal Stem Cell

Charles K. F. Chan, Eun Young Seo, James Y. Chen et al. · Cell · 2015 · 785 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +12

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Branimir I. Šikić, Nehal J. Lakhani, Amita Patnaik et al. · Journal of Clinical Oncology · 2019 · 590 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study

Jeffrey J. Bazarian, Peter Biberthaler, Robert D. Welch et al. · The Lancet Neurology · 2018 · 582 citations · Full text

Medicine, Neurology, Radiology +15

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

Amira Barkal, Kipp Weiskopf, Kevin S. Kao et al. · Nature Immunology · 2017 · 558 citations · Full text

Life Sciences, Immunology, Oncology +16